NCT05277051 2025-12-19
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
GlaxoSmithKline
Phase 1 Recruiting
GlaxoSmithKline
GlaxoSmithKline
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Gruppo Oncologico del Nord-Ovest